Africa
Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free
Novartis commemorates World CML Day by announcing the latest milestone in its unique clinical trial program evaluating the potential for patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) to maintain undetectable levels of disease […]
